May 2022: The implementation date for the sixth round of national centralized procurement has been finalized.


Release date:

2022-01-06

On January 6, the Shanghai Sunshine Pharmaceutical Procurement Website issued the “Notice on the Announcement of the First-Year Contracted Purchase Quantities for the National Centralized Drug Procurement (Insulin Special)” . The notice stipulates that the winning results of this insulin‑specific centralized procurement will take effect in May 2022, with the exact implementation date subject to local announcements.

On January 6, the Shanghai Sunshine Pharmaceutical Procurement Website issued the “Notice on the Announcement of the First-Year Contracted Purchase Quantities for the National Centralized Drug Procurement (Insulin Special)” . The notice stipulates that the winning results of this insulin‑specific centralized procurement will take effect in May 2022, with the exact implementation date subject to local announcements.

According to the notice, all pharmaceutical institutions have, in accordance with the provisions of the “National Centralized Drug Procurement Document (Insulin Special) (GY-YD2021-3),” completed the confirmation of the contracted procurement volumes for the winning products in the insulin special procurement. The national first-year contracted procurement volumes for the nationally organized centralized drug procurement (insulin special) and the first-year contracted procurement volumes for each region have now been finalized.

According to reports, the national centralized procurement program has now entered its sixth round. From the official launch of the sixth round—focused on insulin—on September 10, 2021, to the announcement of the winning bid results, less than half a year has elapsed.

Original text attached:

Notice on the Publication of the First-Year Agreed Purchase Quantities for the National Centralized Drug Procurement (Insulin Special)

To all relevant units:

In accordance with the work plan, all pharmaceutical institutions have, in compliance with the provisions of the “National Centralized Drug Procurement Document (Insulin Special) (GY-YD2021-3),” completed the confirmation of the contracted procurement volumes for the winning products in the insulin special procurement. The national first-year contracted procurement volumes for the nationally organized centralized drug procurement (insulin special) and the first-year contracted procurement volumes for each region have now been finalized.

Provincial medical insurance authorities may log in to the “National Centralized Drug Procurement Comprehensive Service Platform” (website: http://pub.smpaa.cn/ydsblxt/) and, on the left-hand side, click the “Agreement Procurement Volume Management” menu, then select “View Agreement Procurement Volume” to access the agreed procurement volumes of insulin-winning enterprises in their respective provinces.

Selected enterprises for each insulin product may log in to the “National Centralized Drug Procurement Comprehensive Service Platform” (website: http://pub.smpaa.cn/xxsj/) and, on the left-hand side, click the “Agreement Procurement Volume Inquiry” menu under “National Procurement Bidding Management” to view the agreed procurement volumes for their winning products.

The results of this special centralized procurement for insulin will take effect in May 2022, with the specific implementation date subject to official notices issued by local authorities.

This is to notify you.

National Organization for Joint Procurement of Drugs

January 6, 2022


Leave a Message Online

Please fill out the form, and we will get back to you as soon as possible!

Consultation Service Hotline

86-0717-6555905

Address: No. 509, East Lin Road, Bio-Industrial Park, High-tech Zone, Yichang City, Hubei Province, China

International Marketing Department

Contact: Vivian Guo

Email: Vivian.guo@tianrenpharm.com

Phone: 86-15997560212

WhatsApp: +86-15997560212


All rights reserved: Yichang Tianren Pharmaceutical Co., Ltd.

This website supports both IPv4 and IPv6 bidirectional access.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86%EF%BC%8C%E7%9F%A5%E5%90%8D%EF%BC%8C%E7%BA%A7

Sorry,当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry,The current column has no content!

You can view other columns or return Home